EU health regulator reviewing Pfizer-BioNTech Covid-19 vaccine in real time

The EU health regulator has launched a real-time review of a Covid-19 vaccine developed by US drugmaker Pfizer and Germany's BioNTech, it said on Tuesday, following a similar announcement for rival AstraZeneca's jab last week.

The announcement by the European Medicines Agency (EMA) could speed up the process of approving a successful vaccine in the bloc, by allowing researchers to submit findings in real time, without waiting for studies to conclude.
 

The Pfizer and BioNTech vaccine, along with AstraZeneca's, which is being co-developed by Oxford University, are two of the leading candidates in the race for the first jab to get